The molecular mechanisms underlying the putative role of osteopontin in the chronic
inflammatory disease rheumatoid arthritis are unclear. A study in a murine model of arthritis
now demonstrates that a specific antibody directed against the exposed osteopontin epitope
SLAYGLR is capable of preventing inflammatory cell infiltration in arthritic joints.